The National Institute of Diabetes & Digestive & Kidney Diseases

Help supervise and coordinate several NIDDK network studies – HALT-C, Virahep C

(both hepatitis Studies); DILIN (drug-induced liver injury study), A2ALL (Adult to

adult living donor liver transplantation study), NASH (Non-alcoholic steatohepatitis

study), SyNCH (silymarin trial for hepatitis C and NASH); chair committees in HALTC

and DILIN; advise Director, Liver Disease Branch on relevant liver disease issues,

including Liver Action Plan; organize liver disease-related conferences and workshops:

liaison on hepatitis and other liver diseases to NIH ICs (NIDA, NCCAM, NIAID,

NHLBI, NIAAA), Department of Veterans Affairs, Centers for Disease Control,

Department of Defense, American Association for the Study of Liver Diseases,

University of Witwatersrand, Johannesburg, South Africa

Internship and Residency training, Johannesburg General and

Coronation Hospital, 1961-1963

Residency Internal Medicine and GI/Hepatology Fellowship,

Mt. Sinai Hospital, Chicago, Illinois and VA Medical Center,

Washington DC and Boston Mass, 1964-1967

Chief Gastroenterology and Hepatology, VA Medical Center, Washington DC,
 1978-1998

NIDA, External Advisory Committee; NCI Data Quality

Monitoring Committee; NHLBI Serum Repository Committee

Special Government Employee for Food and Drug Administration

Advisor to International Kidney Disease Improving Global Outcomes Committee

(Guidelines for treatment of hepatitis C in kidney disease);

Guidelines for treatment of hepatitis C for American Association for Study of Liver

Diseases

Editorial Boards

Seminars in Liver Disease; Hellenic Journal of Gastroenterology;

Minerva Gastroenterlogica e Dieteloica